Stimcell Energetics, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- David Jeffs
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 1130 Pender Street, West Vancouver BC Canada V6E 4A4
- IPO Date
- Aug 29, 2013
- CIK
- 0001493712
- Website
- stimcell.com
- Similar Companies
- Business
- StimCell Energetics, Inc. specializes in the development, manufacture, and commercialization of microcurrent-based health devices for professional and consumer use, focusing on wellness, pain management, and diagnostic applications; the company markets the eBalance Pro System for clinical settings and the eBalance Home System for at-home use, controlled by the eBalance Console that integrates multiple microcurrent algorithms. The company emphasizes its proprietary eBalance® technology as a core platform for therapeutic and non-therapeutic health products, aiming to empower individuals to manage health conditions through at-home solutions and practitioner-enabled therapies. StimCell operates primarily in the United States with corporate presence in Canada, and references indicate ongoing development and potential product iterations targeting broader consumer accessibility and streamlined, cost-effective designs. The firm was founded in the 2010s and maintains headquarters in Vancouver, British Columbia, with continued development activities and regulatory filings in North American markets. In addition to its core device systems, StimCell highlights potential ancillary offerings including diagnostic features and software-enabled workflow enhancements for both professional clinics and home users. The company’s product strategy centers on scalable microcurrent technology platforms to address diabetes-related complications, neuropathy, hypertension, kidney function concerns, and related conditions, with ongoing updates to device form factors, cost structure, and user interfaces to broaden adoption. StimCell maintains a business model that combines device sales, potential consumables or accessories, and related software services, aiming to establish a multi-channel presence across clinical and consumer healthcare environments. The company’s geographic footprint and strategic partner discussions appear oriented toward expanding distribution, clinical collaborations, and potential licensing or co-development opportunities in North American and selected international markets. StimCell’s corporate profile reflects an emphasis on R&D-driven product evolution, regulatory compliance across jurisdictions, and a pathway toward increased access to microcurrent-based health solutions for home and clinical use.
Stonegate Initiates Coverage on StimCell Energetics Inc. (STME)
StimCell Energetics Engages Stonegate Capital Partners for Research Coverage and Institutional Investor Outreach
StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function
StimCell Energetics Inc. Successfully Uplists to OTCQB Market
StimCell Energetics Provides Sneak Peek at eBalance Redesign Progress and Announces Shares for Debt Transaction and the Engagement of Independent Investor Relations Consultant
StimCell Energetics Inc. (Formerly "Cell MedX Corp.") Announces Major Corporate Updates and Rebranding
Cell MedX Corp. Closes Private Placement Financing
Cell MedX Corp. Announces Resignation of Director
Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer